Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
ConditionChronic Pulmonary Aspergillosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorImperial College London
About this trial
To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.
Eligibility criteria
Qualifiers
All patients >/= 18 years old and able to provide informed consent
Patients with a diagnosis of chronic pulmonary aspergillosis
To speak and understand English
Able to provide informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
3Ninewells Hospital & Medical SchoolDD1 9SY, Dundee United Kingdom
Imperial College London London United Kingdom
Manchester NHS Foundation Trust Manchester United Kingdom
Sponsors and collaborators
Imperial College London
Lead sponsor
Manchester University NHS Foundation Trust
Collaborator
Tayside Medical Science Centre
Collaborator
Source ClinicalTrials.gov